Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis. (Q51750750)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 June 2007

edit

Language	Label	Description	Also known as
English	Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis.	scientific article published on 7 June 2007

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17559367

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/17559367

title

Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17559367

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/17559367

author name string

Steve Lontos

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17559367

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/17559367

Paul J Gow

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17559367

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/17559367

Rhys B Vaughan

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17559367

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/17559367

Peter W Angus

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17559367

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/17559367

publication date

7 June 2007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17559367

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/17559367

published in

Journal of Gastroenterology and Hepatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17559367

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/17559367

volume

23

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17559367

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/17559367

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17559367

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/17559367

page(s)

252-255

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17559367

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/17559367

cites work

A prospective study of bacterial infections in patients with cirrhosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04926.X

retrieved

21 January 2018

Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04926.X

retrieved

21 January 2018

Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04926.X

retrieved

21 January 2018

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04926.X

retrieved

21 January 2018

Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04926.X

retrieved

21 January 2018

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04926.X

retrieved

21 January 2018

Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04926.X

retrieved

21 January 2018

Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04926.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1440-1746.2007.04926.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17559367

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/17559367

PubMed publication ID

17559367

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17559367

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/17559367

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51750750&oldid=1229557892"